ALLO earnings
Allogene Therapeutics (ALLO) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
ALLO earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | -0.13 | -0.17 | 24.14% | $4.64M |
| Q1 2026 | May 13, 2026 | -0.18 | -0.19 | 5.26% | – |
| Q4 2025 | Mar 12, 2026 | -0.17 | -0.25 | 32.00% | – |
| Q3 2025 | Nov 6, 2025 | -0.19 | -0.23 | 17.39% | – |
| Q2 2025 | Aug 13, 2025 | -0.23 | -0.28 | 17.86% | – |
| Q1 2025 | May 13, 2025 | -0.28 | -0.28 | 0.00% | – |
| Q4 2024 | Mar 13, 2025 | -0.28 | -0.34 | 17.65% | – |
| Q3 2024 | Nov 7, 2024 | -0.27 | -0.34 | 20.59% | – |
| Q2 2024 | Aug 7, 2024 | -0.32 | -0.35 | 8.57% | – |
| Q1 2024 | May 13, 2024 | -0.38 | -0.38 | 0.00% | $22.00K |
| Q4 2023 | Mar 14, 2024 | -0.43 | -0.47 | 8.51% | -$44.00K |
| Q3 2023 | Nov 2, 2023 | -0.37 | -0.53 | 30.19% | $22.00K |
| Aug 2, 2023 | -0.53 | -0.59 | 10.17% | – | |
| May 3, 2023 | -0.68 | -0.63 | -7.94% | – | |
| Feb 28, 2023 | -0.66 | -0.71 | 7.04% | – | |
| Nov 2, 2022 | -0.58 | -0.62 | 6.45% | – | |
| Aug 9, 2022 | -0.52 | -0.61 | 14.75% | – | |
| May 4, 2022 | -0.56 | -0.59 | 5.08% | – | |
| Feb 23, 2022 | -0.54 | -0.61 | 11.48% | – | |
| Nov 4, 2021 | -0.57 | -0.56 | -1.79% | – |
- ALLO reports next on Nov 5, 2026, with EPS of -0.15 expected.
- ALLO beat EPS estimates in 28 of its last 32 reports.
Updated 2026-11-02 19:12 UTC